demonstrate that ACVR2A inactivation in HCC induces hyperglycolysis by disrupting SMAD4 signaling, leading to LDHA upregulation, lactate secretion, and regulatory T cell recruitment. This evidence concerns the gene ACVR2A and hepatocellular carcinoma.